Armistice Capital »

Fiserv shares owned by Armistice Capital

Quarter-by-quarter ownership of Fiserv (FISV) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Fiserv

Tip: Access up to 7 years of quarterly data

All positions including Fiserv held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fiserv by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $462k 9.4k 49.05
2024-03-31 $200k 1.3k 159.82

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Fiserv

Dodge & Cox
BlackRock
Vanguard Capital Management
State Street Corporation
Harris Associates L.P
Vanguard Portfolio Management
Geode Capital Management
Capital World Investors
First Eagle Investment Management
Hotchkis and Wiley Capital Management
Federated Investors
FMR
Morgan Stanley
Invesco
Norges Bank Investment Management

View all funds holding Fiserv